Seagen Inc.
Glycan-Interacting Compounds and Methods of Use
Last updated:
Abstract:
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
Status:
Application
Type:
Utility
Filling date:
26 May 2021
Issue date:
24 Feb 2022